Literature DB >> 14574162

The inframe MSH2 codon 596 deletion is linked with HNPCC and associated with lack of MSH2 protein in tumours.

Astrid T Stormorken1, Wolfram Müller, Annika Lindblom, Ketil Heimdal, Steinar Aase, Inger Marie Bowitz Lothe, Tove Norèn, Juul T Wijnen, Gabriela Möslein, Pål Møller.   

Abstract

Hereditary nonpolyposis colorectal cancer (HNPCC) may be caused by germline truncating mutations in DNA mismatch repair (MMR) genes. Whether or not missense or inframe mutations are disease-associated has become a practical clinical problem, because predictive genetic testing is employed to select high-risk persons for clinical examinations. Clinical examinations may reveal polyps to be removed and prevent cancer. One large kindred applying for health care had a N596del mutation in the MSH2 gene. The aim of this study was to determine whether or not the inframe mutation in this family was associated with disease, and to examine the tumours for presence of the MSH2 protein by immunohistochemistry. We demonstrated that the mutation was linked to disease with lod score 5.7 in the family, and all examined, but one manifest cancer, lacked the MSH2 protein.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14574162     DOI: 10.1023/a:1023362205205

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  22 in total

1.  MSH2 genomic deletions are a frequent cause of HNPCC.

Authors:  J Wijnen; H van der Klift; H Vasen; P M Khan; F Menko; C Tops; H Meijers Heijboer; D Lindhout; P Møller; R Fodde
Journal:  Nat Genet       Date:  1998-12       Impact factor: 38.330

2.  Interactions of human hMSH2 with hMSH3 and hMSH2 with hMSH6: examination of mutations found in hereditary nonpolyposis colorectal cancer.

Authors:  S Guerrette; T Wilson; S Gradia; R Fishel
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

3.  Lack of MSH2 and MSH6 characterizes endometrial but not colon carcinomas in hereditary nonpolyposis colorectal cancer.

Authors:  P Schweizer; A L Moisio; S A Kuismanen; K Truninger; R Vierumäki; R Salovaara; J Arola; R Butzow; J Jiricny; P Peltomäki; M Nyström-Lahti
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

4.  Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair.

Authors:  M Strand; T A Prolla; R M Liskay; T D Petes
Journal:  Nature       Date:  1993-09-16       Impact factor: 49.962

5.  Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients.

Authors:  W J de Leeuw; J Dierssen; H F Vasen; J T Wijnen; G G Kenter; H Meijers-Heijboer; A Brocker-Vriends; A Stormorken; P Moller; F Menko; C J Cornelisse; H Morreau
Journal:  J Pathol       Date:  2000-11       Impact factor: 7.996

6.  Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis.

Authors:  E D Lynch; E A Ostermeyer; M K Lee; J F Arena; H Ji; J Dann; K Swisshelm; D Suchard; P M MacLeod; S Kvinnsland; B T Gjertsen; K Heimdal; H Lubs; P Møller; M C King
Journal:  Am J Hum Genet       Date:  1997-12       Impact factor: 11.025

7.  Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation.

Authors:  F E M Rijcken; H Hollema; J H Kleibeuker
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

8.  The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer.

Authors:  R Fishel; M K Lescoe; M R Rao; N G Copeland; N A Jenkins; J Garber; M Kane; R Kolodner
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

9.  Expression of wild-type p53 is not compatible with continued growth of p53-negative tumor cells.

Authors:  P Johnson; D Gray; M Mowat; S Benchimol
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

10.  Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer.

Authors:  F S Leach; N C Nicolaides; N Papadopoulos; B Liu; J Jen; R Parsons; P Peltomäki; P Sistonen; L A Aaltonen; M Nyström-Lahti
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

View more
  2 in total

1.  Novel MLH1 frameshift mutation in an extended hereditary nonpolyposis colorectal cancer family.

Authors:  Tanya-Kirilova Kadiyska; Radka-Petrova Kaneva; Dimitar-Georgiev Nedin; Alexandrina-Borisova Alexandrova; Antonina-Todorova Gegova; Stoyan-Ganchev Lalchev; Tatyana Christova; Vanio-Ivanov Mitev; Juergen Horst; Nadja Bogdanova; Ivo-Marinov Kremensky
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

2.  Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriers.

Authors:  Wenche Sjursen; Bjørn Ivar Haukanes; Eli Marie Grindedal; Harald Aarset; Astrid Stormorken; Lars F Engebretsen; Christoffer Jonsrud; Inga Bjørnevoll; Per Arne Andresen; Sarah Ariansen; Liss Anne S Lavik; Bodil Gilde; Inger Marie Bowitz-Lothe; Lovise Maehle; Pål Møller
Journal:  J Med Genet       Date:  2010-06-28       Impact factor: 6.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.